Skip to main content
. Author manuscript; available in PMC: 2014 Jan 3.
Published in final edited form as: Kidney Int. 2011 Mar 9;80(2):10.1038/ki.2011.56. doi: 10.1038/ki.2011.56

Figure 6. Quantitative western blotting for active β-catenin shows no difference between wildtype and Pkd2/WS25 kidneys.

Figure 6

Western blots for active β-catenin were performed on nuclear lysates from E16 (A) and 2 week old (B) kidneys. Quantification relative to actin demonstrates no change in the levels of active β-catenin among the different genotype groups. M, marker.